Contribution: Industrial Research Assistance Program – Contributions to Firms
Elanco Canada Limited
$742,264.00
Vaccine Development for Canadian aquaculture
FY 2020-21 · 2021-02-01
Summary
This project will seek to redevelop two approved vaccines for farmed salmonids in Canada. This life cycle management project will introduce an antigen to both vaccines and offer a new indication to the market.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Charlottetown|Charlottetown, Prince Edward Island, Canada
Recipient Type
For-profit organization
Business Number
888756087
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-02-01 | 2020-21 | $677,511.00 |
| 2 | 2021-02-01 | 2020-21 | $742,264.00 |
As published
Additional Information
This agreement has been amended 2 time(s). The total amended value is 64,753 dollars.
Additional Information (French)
Cet accord a été modifié 2 fois La valeur totale des modifications est de 64 753 dollars.
Agreement End Date
2023-05-31
Agreement Number
969357
Agreement Start Date
2021-02-01
Agreement Title
Vaccine Development for Canadian aquaculture
Agreement Title (French)
Développement de vaccins pour l'aquaculture canadienne
Agreement Type
Contribution
Agreement Value
$742,264.00
Amendment Date
2023-03-14
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will seek to redevelop two approved vaccines for farmed salmonids in Canada. This life cycle management project will introduce an antigen to both vaccines and offer a new indication to the market.
Description (French)
Ce projet vise à redévelopper deux vaccins approuvés pour les salmonidés d'élevage au Canada. Ce projet de gestion du cycle de vie permettra d'introduire un antigène dans les deux vaccins et d'offrir une nouvelle indication sur le marché.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Charlottetown
Federal Riding (French)
Charlottetown
Federal Riding Number
11002
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
888756087
Recipient City
Charlottetown|Charlottetown
Recipient Country
CA
Recipient Legal Name
Elanco Canada Limited
Recipient Postal Code
C1E 2A7
Recipient Province or Territory
PE
Recipient Type
F
Reference Number
172-2020-2021-Q4-969357
